Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
Pediatric Blood & Cancer
|
May 28, 2020
Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1
Amy E Armstrong, Steven D Rhodes, Abbi Smith, et al.
Genes & Development
|
April 8, 2015
Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin
Colleen Wu, Erinn B Rankin, Laura Castellini, et al.
The Journal of Clinical Investigation
|
December 11, 2012
Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk
Karl Staser, Su-Jung Park, Steven D Rhodes, et al.
Stem Cell Reports
|
May 31, 2016
Loss of Asxl1 Alters Self-Renewal and Cell Fate of Bone Marrow Stromal Cell, Leading to Bohring-Opitz-like Syndrome in Mice
Peng Zhang, Caihong Xing, Steven D Rhodes, et al.
Molecular Cancer Therapeutics
|
September 19, 2019
Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of <i>Nf1</i>-Deficient Mice
Ciersten A Burks, Steven D Rhodes, Waylan K Bessler, et al.
Cancer Research Communications
|
March 20, 2025
PLK1 Inhibition Induces Synthetic Lethality in Fanconi Anemia Pathway-Deficient Acute Myeloid Leukemia
Aditya S Sheth, Ka-Kui Chan, Sheng Liu, et al.
The Journal of Biological Chemistry
|
May 31, 2020
Genetic disruption of the small GTPase RAC1 prevents plexiform neurofibroma formation in mice with neurofibromatosis type 1
Julie A Mund, SuJung Park, Abbi E Smith, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
May 25, 2013
Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model
Steven D Rhodes, Xiaohua Wu, Yongzheng He, et al.
Haematologica
|
March 26, 2017
An abnormal bone marrow microenvironment contributes to hematopoietic dysfunction in Fanconi anemia
Yuan Zhou, Yongzheng He, Wen Xing, et al.
The Journal of Clinical Investigation
|
July 1, 2025
A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice
Su Jung Park, Jodi L Lukkes, Ka-Kui Chan, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
Pediatric Blood & Cancer
|
May 28, 2020
Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1
Amy E Armstrong, Steven D Rhodes, Abbi Smith, et al.
Genes & Development
|
April 8, 2015
Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin
Colleen Wu, Erinn B Rankin, Laura Castellini, et al.
The Journal of Clinical Investigation
|
December 11, 2012
Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk
Karl Staser, Su-Jung Park, Steven D Rhodes, et al.
Stem Cell Reports
|
May 31, 2016
Loss of Asxl1 Alters Self-Renewal and Cell Fate of Bone Marrow Stromal Cell, Leading to Bohring-Opitz-like Syndrome in Mice
Peng Zhang, Caihong Xing, Steven D Rhodes, et al.
Molecular Cancer Therapeutics
|
September 19, 2019
Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of <i>Nf1</i>-Deficient Mice
Ciersten A Burks, Steven D Rhodes, Waylan K Bessler, et al.
Cancer Research Communications
|
March 20, 2025
PLK1 Inhibition Induces Synthetic Lethality in Fanconi Anemia Pathway-Deficient Acute Myeloid Leukemia
Aditya S Sheth, Ka-Kui Chan, Sheng Liu, et al.
The Journal of Biological Chemistry
|
May 31, 2020
Genetic disruption of the small GTPase RAC1 prevents plexiform neurofibroma formation in mice with neurofibromatosis type 1
Julie A Mund, SuJung Park, Abbi E Smith, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
May 25, 2013
Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model
Steven D Rhodes, Xiaohua Wu, Yongzheng He, et al.
Haematologica
|
March 26, 2017
An abnormal bone marrow microenvironment contributes to hematopoietic dysfunction in Fanconi anemia
Yuan Zhou, Yongzheng He, Wen Xing, et al.
The Journal of Clinical Investigation
|
July 1, 2025
A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice
Su Jung Park, Jodi L Lukkes, Ka-Kui Chan, et al.
Page
of 5